Suppr超能文献

相似文献

1
Comparative Analysis of the Capacity of the Species To Elicit Vaginal Immunopathology.
Infect Immun. 2018 Nov 20;86(12). doi: 10.1128/IAI.00527-18. Print 2018 Dec.
2
Candidalysin Drives Epithelial Signaling, Neutrophil Recruitment, and Immunopathology at the Vaginal Mucosa.
Infect Immun. 2018 Jan 22;86(2). doi: 10.1128/IAI.00645-17. Print 2018 Feb.
5
The bacterial communities in vagina of different Candida species-associated vulvovaginal candidiasis.
Microb Pathog. 2023 Apr;177:106037. doi: 10.1016/j.micpath.2023.106037. Epub 2023 Feb 25.
6
NLRP3 inflammasome is a key player in human vulvovaginal disease caused by Candida albicans.
Sci Rep. 2017 Dec 19;7(1):17877. doi: 10.1038/s41598-017-17649-8.

引用本文的文献

1
New insights toward personalized therapies for vulvovaginal candidiasis and vaginal co-infections.
Front Microbiol. 2025 Aug 8;16:1625952. doi: 10.3389/fmicb.2025.1625952. eCollection 2025.
2
Insights into the evolution of Candidalysin and recent developments.
Arch Microbiol. 2025 Jul 31;207(9):206. doi: 10.1007/s00203-025-04414-z.
5
Host-microbe interaction paradigms in acute and recurrent vulvovaginal candidiasis.
Cell Host Microbe. 2024 Oct 9;32(10):1654-1667. doi: 10.1016/j.chom.2024.08.018.
6
Inflammatory cytokine signalling in vulvovaginal candidiasis: a hot mess driving immunopathology.
Oxf Open Immunol. 2024 Aug 17;5(1):iqae010. doi: 10.1093/oxfimm/iqae010. eCollection 2024.
7
Innate immune response to Candida auris.
Curr Opin Microbiol. 2024 Aug;80:102510. doi: 10.1016/j.mib.2024.102510. Epub 2024 Jul 3.
8
Vertebrate and invertebrate animal infection models of Candida auris pathogenicity.
Curr Opin Microbiol. 2024 Aug;80:102506. doi: 10.1016/j.mib.2024.102506. Epub 2024 Jun 25.
9
Vulvovaginal candidiasis culture results from a major national commercial laboratory, United States, 2019-2023.
Am J Obstet Gynecol. 2024 Sep;231(3):e101-e104. doi: 10.1016/j.ajog.2024.04.048. Epub 2024 May 6.
10
SWI/SNF complex-mediated chromatin remodeling in promotes immune evasion.
iScience. 2024 Mar 27;27(4):109607. doi: 10.1016/j.isci.2024.109607. eCollection 2024 Apr 19.

本文引用的文献

1
Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern.
BMC Womens Health. 2018 Jun 15;18(1):94. doi: 10.1186/s12905-018-0607-z.
2
NLRP3 inflammasome is a key player in human vulvovaginal disease caused by Candida albicans.
Sci Rep. 2017 Dec 19;7(1):17877. doi: 10.1038/s41598-017-17649-8.
3
Candidalysin Drives Epithelial Signaling, Neutrophil Recruitment, and Immunopathology at the Vaginal Mucosa.
Infect Immun. 2018 Jan 22;86(2). doi: 10.1128/IAI.00645-17. Print 2018 Feb.
5
Whole Genome Sequence of the Heterozygous Clinical Isolate 81-B-5.
G3 (Bethesda). 2017 Sep 7;7(9):2883-2889. doi: 10.1534/g3.117.043547.
7
Fungal Profile of Vulvovaginal Candidiasis in a Tertiary Care Hospital.
J Clin Diagn Res. 2017 Mar;11(3):DC06-DC09. doi: 10.7860/JCDR/2017/23578.9475. Epub 2017 Mar 1.
8
Specific pathways mediating inflammasome activation by Candida parapsilosis.
Sci Rep. 2017 Feb 22;7:43129. doi: 10.1038/srep43129.
9
Prevalence of Candida spp. in cervical-vaginal samples and the in vitro susceptibility of isolates.
Braz J Microbiol. 2017 Jan-Mar;48(1):145-150. doi: 10.1016/j.bjm.2016.09.006. Epub 2016 Oct 4.
10
Candidalysin is a fungal peptide toxin critical for mucosal infection.
Nature. 2016 Apr 7;532(7597):64-8. doi: 10.1038/nature17625. Epub 2016 Mar 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验